Precision Medicine Podcast

Mr. Chet Burrell, former president and CEO of Care First Blue Cross Blue Shield and Executive Chairman of the Intervention Insights Board of Directors, discusses the challenges payers face in managing the growth of precision medicine for cancer care and why he's championing Trapelo's precision diagnostic platform as the first collaborative technology solution.

In this first episode with Dr. Jack West, we discuss the state of precision oncology and the challenges providers face when it comes to performing the right molecular tests to appropriately prescribe targeted therapies. Leave a review and subscribe here.

In this first episode with Dr. Jack West, we discuss the state of precision oncologyand the challenges providers face when it comes to performing the right molecular tests to appropriately prescribe targeted therapies. Leave a review and subscribe here.

Laboratories could be considered the epicenter of the precision medicine industry, so we were thrilled to have Dr. Michael Astion, Medical Director for the Department of Laboratories at Seattle Children's Hospital join us. In this episode, he introduces us to PLUGS , (Patient Centered Laboratory Utilization Guidance Service) a grassroots program he co-founded that exists to promote and strengthen...

We’ve received many questions about the challenges clinicians face in knowing when to use pharmacogenetic tests in practice. So we invited our resident "genome educator" back! Inthis episodeJeanette McCarthy, co-founder of Precision Medicine Advisors, returns to address those questions and discuss some of the issues health care providers face. Listen here.

Dr. Michael Kolodziej is Vice President and Chief Innovation Officer at ADVI Health, a Washington, D.C.-based healthcare consulting and strategy firm, and a pioneer in developing value-based reimbursement models for cancer care. Having seen him present his talk, “The Healthcare Landscape of 2025: 3 Trends That Can Change Cancer Care Forever,” at a Florida Association of Clinical Oncology (FLASCO)...

Dr. Windy Dean-Colomb, an MD Anderson-trained MD, PhD, and practicing medical oncologist, and Dr. Clayton Yates, a professor of biology at Tuskegee University and director of the university's Multidisciplinary Center for Biomedical Research, join us to discuss the importance of studying and addressing racial disparities in oncology.

How precision medicine is moving oncologists away from population-based treatments to more patient-appropriate care. Dr. Lee Newcomer, board-certified oncologist and former SVP of oncology and genetics at UnitedHealthcare, answers pressing questions about the current costs of cancer care, how diagnostics are currently reimbursed and who should control the development of those diagnostics. His answ...

Precision Medicine Podcast guest Dr. Sandeep “Bobby” Reddy talks about how he became an early adopter of precision medicine and the opportunities that exist to present its economic benefits. Listen to the full episode here .

  In epsiode 6, Dr. Peter Beitsch, Chief Physician of the Dallas Surgical Group and an executive with the TME Breast Cancer Network, joined us to discuss his study published by the Clinical Journal of Oncology titled, Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? During the episode, he spoke in-depth about the results of that study and the implic...

Clynt Taylor, CEO of Intervention Insights, shares his insight in working with large cancer centers to identify and address barriers to precision medicine in cancer care.

In this episode, we welcome guest, Chris Wells, VP of Public Affairs for the Personalized Medicine Coalition, a collaboration of innovators, scientists, patients, providers, and payers who work to further the understanding and adoption of personalized medicine across the healthcare system.

Luba Greenwood, J.D., Strategic Business Development at Google Life Sciences, discusses innovative digital health tools in precision medicine and the greater healthcare space.  

In this episode of the Precision Medicine Podcast , Brad Power, a courageous journalistic voice and lymphoma survivor, shares why he's fighting for greater access to precision medicine in clinical practice. Brad has worked as a re-engineering consultant and has authored over 75 articles for the Harvard Business Review.  

In this episode, Jeanette McCarthy, co-founder of Precision Medicine Advisors and genome educator, joins us to discuss the importance of educating everyone involved in precision medicine—including healthcare providers, payers, and even patients—about its day-to-day applications.

NCCN testing guidelines have long been a key tool that payers use to decide which cancer patients will be covered for genetic testing. With the rapid growth of precision medicine, it has become more important than ever to ensure every patient that should be tested is tested, raising new questions about how effectively and consistently current guidelines are applied. Dr. Peter Beitsch addresses som...

All of the conversations we have here at the Precision Medicine Podcast are focused on uncovering both barriers and solutions to realizing the promise of precision medicine. Having the opportunity to speak with Laura Holmes Haddad, an author, speaker, and breast cancer “thriver,” was especially meaningful, because it serves as a reminder that improving patient care—and giving every patient the bes...

Personalized medicine offers new hope for cancer patients, but those such a significant illness are not the only ones who can benefit from it. Dr. Keith Stewart joined us for an eye-opening discussion about how his team at the Mayo Clinic is exploring the possibilities of using precision medicine for the prevention and maintenance of a “healthy genome” in people who have not yet developed a diseas...

Diagnostics tests are critical for properly applying Precision Medicine in cancer care, yet they are still undervalued by payers. In a recent podcast, we had the privilege of speaking with Hannah Mamuszka, Ph. D. founder of Alva10 , a company aimed at breaking the cycle of commoditization in diagnostics and bringing radically new tests to bear on value-based healthcare. Our conversation centered a...

In oncology today, diagnostic technology tools are key to helping scientists unlock the potential of precision medicine, so we were thrilled when Dave Messina, Chief Operating Officer of Cofactor Genomics, agreed to be a guest on The Precision Medicine podcast to talk about the importance of such tools. <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3...

The impact of precision medicine is on everyone’s mind these days—especially those on the front lines of cancer care. So, it was an honor for to speak with, and get the perspective of, one of the most vocal and forward-thinking pathologists in oncology today: Doctor Tony Magliocco, Chair of the Department of Pathology and Executive Director of Esoteric Laboratory Services at H. Lee Moffitt Cancer...